Abiopharma

🔍 Fendley Steven S. (Executive)

Company: KRATOS DEFENSE & SECURITY SOLUTIONS, INC. (KTOS)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Sold 1,512 shares of Common Stock at $68.2803 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 363,511.00 | transaction_form_type: 4 | Footnotes: F1, F2, F6
• Sold 3,644 shares of Common Stock at $69.3932 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 359,867.00 | transaction_form_type: 4 | Footnotes: F1, F3, F6
• Sold 944 shares of Common Stock at $70.4785 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 358,923.00 | transaction_form_type: 4 | Footnotes: F1, F4, F6
• Sold 900 shares of Common Stock at $71.6439 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 358,023.00 | transaction_form_type: 4 | Footnotes: F1, F5, F6

Footnotes:

• F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.00 to $68.89 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.01 to $69.96 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.005 to $70.90 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.34 to $71.85 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F6: Includes approximately 2,351 shares held through Issuer's 401(k) Plan.